|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.688
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.449
|
|
|
amide transport
|
GO:0042886 |
138 |
0.252
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.230
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.186
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.186
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.156
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.153
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.147
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.141
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.140
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.139
|
|
|
gland development
|
GO:0048732 |
330 |
0.134
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.134
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.128
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.125
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.125
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.124
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.124
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.123
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.123
|
|
|
placenta development
|
GO:0001890 |
140 |
0.120
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.119
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.119
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.118
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.116
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.114
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.112
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.112
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.111
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.109
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.108
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.105
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.104
|
|
|
memory
|
GO:0007613 |
58 |
0.102
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.100
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.100
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.099
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.098
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.096
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.095
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.094
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.094
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.093
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.093
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.093
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.092
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.089
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.089
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.088
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.088
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.087
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.084
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.083
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.082
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.081
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.081
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.079
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.078
|
Rat |
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.078
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.077
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.077
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.077
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.076
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.076
|
|
|
cation transport
|
GO:0006812 |
399 |
0.076
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.075
|
|
|
organ or tissue specific immune response
|
GO:0002251 |
13 |
0.074
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.073
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.073
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.072
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.071
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.071
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.068
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.067
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.066
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.066
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.066
|
|
|
regulation of appetite
|
GO:0032098 |
12 |
0.066
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.065
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.065
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.064
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.064
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.063
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.063
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.063
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.063
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.063
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.062
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.062
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.062
|
|
|
protein processing
|
GO:0016485 |
163 |
0.062
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.061
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.061
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.061
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.060
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.060
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.060
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.059
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.058
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.058
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.058
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.058
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.057
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.057
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.057
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.057
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.056
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.055
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.055
|
|
|
histamine uptake
|
GO:0051615 |
1 |
0.054
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.054
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.054
|
|
|
lactation
|
GO:0007595 |
25 |
0.053
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.053
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.052
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.052
|
|
|
organ growth
|
GO:0035265 |
117 |
0.052
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.052
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.051
|
|
|
renal system development
|
GO:0072001 |
225 |
0.051
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.051
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.051
|
|
|
retinoic acid metabolic process
|
GO:0042573 |
12 |
0.050
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.049
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.049
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.048
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.048
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.048
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.048
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.047
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.047
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.047
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.046
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.046
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.046
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.046
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.046
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.046
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.045
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.045
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.045
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.045
|
|
|
urate transport
|
GO:0015747 |
1 |
0.045
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.045
|
|
|
maternal process involved in female pregnancy
|
GO:0060135 |
32 |
0.044
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.044
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.044
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.044
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.044
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.044
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.044
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.044
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.043
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.043
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.042
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.042
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.042
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.042
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.042
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.042
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.041
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.041
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.041
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.041
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.041
|
|
|
renal system process
|
GO:0003014 |
48 |
0.041
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.041
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.040
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.040
|
|
|
bone development
|
GO:0060348 |
120 |
0.040
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.040
|
|
|
clara cell differentiation
|
GO:0060486 |
4 |
0.040
|
|
|
plasma cell differentiation
|
GO:0002317 |
3 |
0.040
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.040
|
|
|
regulation of timing of cell differentiation
|
GO:0048505 |
11 |
0.040
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.039
|
|
|
lipid oxidation
|
GO:0034440 |
29 |
0.039
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.039
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.039
|
|
|
g protein coupled receptor internalization
|
GO:0002031 |
3 |
0.039
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.039
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.038
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.038
|
|
|
positive regulation of apoptotic process involved in morphogenesis
|
GO:1902339 |
4 |
0.038
|
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.038
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.038
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.038
|
|
|
forelimb morphogenesis
|
GO:0035136 |
40 |
0.038
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.038
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.038
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.038
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.037
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.037
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.037
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.037
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.037
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.037
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.036
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.036
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.036
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.036
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.036
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.036
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.036
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.035
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.035
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
25 |
0.035
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.035
|
|
|
skin development
|
GO:0043588 |
220 |
0.035
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.035
|
|
|
anion transport
|
GO:0006820 |
177 |
0.034
|
|
|
lung induction
|
GO:0060492 |
3 |
0.034
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.034
|
|
|
lung development
|
GO:0030324 |
164 |
0.034
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.034
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.034
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.034
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.034
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.034
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.034
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.034
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.033
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.033
|
|
|
multicellular organismal water homeostasis
|
GO:0050891 |
23 |
0.033
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.032
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.032
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.032
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.032
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.032
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.032
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.032
|
|
|
negative regulation of behavior
|
GO:0048521 |
14 |
0.032
|
|
|
regulation of saliva secretion
|
GO:0046877 |
2 |
0.032
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.032
|
|
|
mammary gland lobule development
|
GO:0061377 |
22 |
0.032
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.031
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.031
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.031
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.031
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.031
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.031
|
|
|
response to drug
|
GO:0042493 |
75 |
0.031
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.031
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.031
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.030
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.030
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.030
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.030
|
|
|
atrioventricular node cell fate commitment
|
GO:0060929 |
1 |
0.030
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.030
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.030
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.030
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.030
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.030
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.030
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.030
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.030
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.030
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.030
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.029
|
|
|
tube formation
|
GO:0035148 |
140 |
0.029
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.029
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.029
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.029
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.029
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.029
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.029
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.028
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.028
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.028
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.028
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.028
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.028
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.028
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.028
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.028
|
|
|
antibacterial humoral response
|
GO:0019731 |
8 |
0.028
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.028
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.028
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.028
|
|
|
midgut development
|
GO:0007494 |
4 |
0.028
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.028
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.028
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.027
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.027
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.027
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.027
|
|
|
regulation of glutamate metabolic process
|
GO:2000211 |
1 |
0.027
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.027
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.027
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.027
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.027
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.027
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.027
|
|
|
mucosal immune response
|
GO:0002385 |
13 |
0.027
|
|
|
intestinal epithelial cell maturation
|
GO:0060574 |
2 |
0.027
|
|
|
spleen development
|
GO:0048536 |
39 |
0.027
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.027
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.026
|
|
|
intestinal epithelial cell differentiation
|
GO:0060575 |
14 |
0.026
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.026
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.026
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.026
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.026
|
|
|
fat soluble vitamin metabolic process
|
GO:0006775 |
11 |
0.026
|
|
|
purkinje myocyte differentiation
|
GO:0003168 |
1 |
0.026
|
|
|
positive regulation of transcription via serum response element binding
|
GO:0010735 |
1 |
0.026
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.026
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.026
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.026
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.026
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.026
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.026
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.026
|
|
|
ossification
|
GO:0001503 |
216 |
0.026
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.026
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.026
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.025
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.025
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.025
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.025
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.025
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.025
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.025
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.025
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.025
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.025
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.025
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.025
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.025
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.025
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.025
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.025
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.024
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.024
|
|
|
somatostatin receptor signaling pathway
|
GO:0038169 |
2 |
0.024
|
|
|
cellular divalent inorganic anion homeostasis
|
GO:0072501 |
3 |
0.024
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.024
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.024
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.024
|
|
|
epinephrine transport
|
GO:0048241 |
1 |
0.024
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.024
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.024
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.024
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.024
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.024
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.024
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.024
|
|
|
keratinocyte proliferation
|
GO:0043616 |
21 |
0.024
|
|
|
cgmp biosynthetic process
|
GO:0006182 |
13 |
0.024
|
|
|
positive regulation of branching involved in lung morphogenesis
|
GO:0061047 |
4 |
0.024
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.024
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.024
|
|
|
somatotropin secreting cell development
|
GO:0060133 |
2 |
0.024
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.023
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.023
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.023
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.023
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.023
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.023
|
|
|
diacylglycerol biosynthetic process
|
GO:0006651 |
2 |
0.023
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.023
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.023
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.023
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.023
|
|
|
regulation of antimicrobial peptide biosynthetic process
|
GO:0002805 |
1 |
0.023
|
|
|
cardiac pacemaker cell fate commitment
|
GO:0060927 |
1 |
0.023
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.023
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.023
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.023
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.023
|
|
|
cgmp metabolic process
|
GO:0046068 |
20 |
0.023
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.023
|
|
|
wound healing
|
GO:0042060 |
157 |
0.023
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.023
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.022
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.022
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.022
|
|
|
histamine induced gastric acid secretion
|
GO:0001697 |
1 |
0.022
|
|
|
positive regulation of growth hormone secretion
|
GO:0060124 |
3 |
0.022
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.022
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.022
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.022
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.022
|
|
|
adenohypophysis development
|
GO:0021984 |
14 |
0.022
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.022
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.022
|
|
|
foregut regionalization
|
GO:0060423 |
3 |
0.022
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.022
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.022
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.022
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.022
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.022
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.022
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.022
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.022
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.022
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.022
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.021
|
|
|
establishment of skin barrier
|
GO:0061436 |
14 |
0.021
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.021
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.021
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.021
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.021
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.021
|
|
|
lung field specification
|
GO:0060424 |
3 |
0.021
|
|
|
mammary gland branching involved in pregnancy
|
GO:0060745 |
6 |
0.021
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.021
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.021
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.021
|
|
|
atrioventricular node cell differentiation
|
GO:0060922 |
2 |
0.021
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.021
|
|
|
innate immune response in mucosa
|
GO:0002227 |
3 |
0.021
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.021
|
|
|
peptide biosynthetic process
|
GO:0043043 |
11 |
0.021
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.021
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.021
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.021
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.021
|
|
|
bronchiole development
|
GO:0060435 |
3 |
0.020
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.020
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.020
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.020
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.020
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.020
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.020
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.020
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.020
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.020
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.020
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.020
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.020
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.020
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.020
|
|
|
cellular phosphate ion homeostasis
|
GO:0030643 |
2 |
0.020
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.020
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.020
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.020
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.020
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.020
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.019
|
|
|
regulation of cardiac muscle cell proliferation
|
GO:0060043 |
23 |
0.019
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.019
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.019
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.019
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.019
|
|
|
left lung development
|
GO:0060459 |
4 |
0.019
|
|
|
pulmonary myocardium development
|
GO:0003350 |
3 |
0.019
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.019
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.019
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.019
|
|
|
regulation of vitamin metabolic process
|
GO:0030656 |
3 |
0.019
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.019
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.019
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.019
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.019
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.019
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.018
|
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
25 |
0.018
|
|
|
gonad development
|
GO:0008406 |
141 |
0.018
|
|
|
kidney development
|
GO:0001822 |
213 |
0.018
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.018
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.018
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.018
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.018
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.018
|
|
|
response to water deprivation
|
GO:0009414 |
1 |
0.018
|
|
|
ventral spinal cord interneuron fate determination
|
GO:0060580 |
1 |
0.018
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.018
|
|
|
glandular epithelial cell differentiation
|
GO:0002067 |
38 |
0.018
|
|
|
lung secretory cell differentiation
|
GO:0061140 |
13 |
0.018
|
|
|
columnar cuboidal epithelial cell development
|
GO:0002066 |
29 |
0.018
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.018
|
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
3 |
0.018
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.018
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.018
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.018
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.018
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.018
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.018
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.017
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.017
|
|
|
fertilization
|
GO:0009566 |
127 |
0.017
|
|
|
mating
|
GO:0007618 |
27 |
0.017
|
|
|
positive regulation of renal sodium excretion
|
GO:0035815 |
2 |
0.017
|
|
|
negative regulation of hormone biosynthetic process
|
GO:0032353 |
4 |
0.017
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.017
|
|
|
neuron death
|
GO:0070997 |
154 |
0.017
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.017
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.017
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.017
|
|